STGD1
Showing 1 - 10 of 10
G1961E-associated Stargardt Disease
Recruiting
- Stargardt Disease
- +4 more
- No intervention
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel
Dec 21, 2022
Healthy Volunteer, Dry Age-related Macular Degeneration Trial (Tinlarebant (LBS-008))
Not yet recruiting
- Healthy Volunteer
- Dry Age-related Macular Degeneration
- Tinlarebant (LBS-008)
- (no location specified)
Dec 19, 2022
Stargardt Disease Trial in Westmead, Perth, Taipei (tinlarebant)
Active, not recruiting
- Stargardt Disease
-
Westmead, New South Wales, Australia
- +2 more
Apr 25, 2022
Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related
Completed
- Stargardt Disease
-
Baltimore, Maryland
- +4 more
Aug 1, 2018
Dominantly Inherited Stargardt's Disease (STGD3) Trial in Salt Lake City (Over the counter DHA/EPA dietary supplementation)
Completed
- Dominantly Inherited Stargardt's Disease (STGD3)
- Over the counter DHA/EPA dietary supplementation
-
Salt Lake City, UtahMoran Eye Center, University of Utah
May 8, 2018
Macular Function at Retinal and Cortical Levels
Unknown status
- Macula; Degeneration, Congenital or Hereditary
- Retina Disorder
- functional magnetic resonance imaging (fMRI)
- +4 more
- (no location specified)
May 3, 2018
Retinal Degeneration, Genetic Disease, Single-Gene Defects Trial in Rome (Saffron supplementation, )
Unknown status
- Retinal Degeneration
- +3 more
- Saffron supplementation
- placebo
-
Rome, ItalyPoliclinico A. Gemelli
Jul 18, 2017